Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2019 Filed Nov 12, 2019 17:47 UTC |
Schwartz Steven ADirector
|
GrantCommon Stock | 98,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001280 · form4-11122019_091140.xml · nonDerivative · entry 1 Schwartz Steven A · CIK 0001782553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,040 F1 · shares: The restricted common stock vest in accordance with the following schedule: 4,085 vested upon the date of grant and the remainder shall vest equally on the first calendar date of each month thereafter until fully vested. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:27 UTC |
Ceed2Med LLC10% owner
|
Disposition to issuerCommon Stock | 750,000 | $0.30 | $225,000.00 |
DisclosureSEC source: 0001415889-19-000686 · form4-06102019_020635.xml · nonDerivative · entry 1 Ceed2Med LLC · CIK 0001764452 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,635,690 Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 21:25 UTC Amendment |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT · 10% owner
|
Disposition to issuerSeries D Preferred Stock (the · Derivative | 16 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-001393 · form4a-09142018_020937.xml · derivative · entry 2 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 3,200,000 shares Expires not disclosed F3 · security: On the Transaction Date, the Purchaser entered into an Agreement to unwind and terminate the Series D Subscription Agreement and void the issuance of the Series D Preferred Stock. The sale was approved in advance by the board of directors of the Company and therefore exempt pursuant to Rule 16b-3(e). F4 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F6 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $200,000. F5 · derivative.expiration_date: The Series D has no expiration date. F7 · balance_after: The original Form 4 filed on September 14, 2018, is amended by this Form 4, which corrects Table II Item 9 to show that the Reporting Person beneficially owns 11 shares of Series D following the reported transaction. No other changes have been made to the original Form 4. Read SEC document |
| September 12, 2018 Filed Sep 14, 2018 20:05 UTC |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT · 10% owner
|
Disposition to issuerSeries D Preferred Stock (the · Derivative | 16 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-001390 · form4-09142018_040901.xml · derivative · entry 2 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16 Underlying: Common Stock · 3,200,000 shares Expires not disclosed F3 · security: On the Transaction Date, the Purchaser entered into an Agreement to unwind and terminate the Series D Subscription Agreement and void the issuance of the Series D Preferred Stock. The sale was approved in advance by the board of directors of the Company and therefore exempt pursuant to Rule 16b-3(e). F4 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F6 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $200,000. F5 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
| September 04, 2018 Filed Sep 13, 2018 16:05 UTC |
Young Philip JDirector · PRESIDENT AND CEO
|
GrantStock Options (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001415889-18-001379 · form4-09132018_040901.xml · derivative · entry 1 Young Philip J · CIK 0001290682 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2023-09-04 F1 · security: 178,125 stock options are fully vested with the remainder vesting monthly in equal increments over a 15 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date. F2 · price: Not applicable. Read SEC document |
| September 04, 2018 Filed Sep 13, 2018 20:05 UTC |
Erickson James R.CHIEF BUSINESS OFFICER
|
GrantStock Options (Right to Buy) · Derivative | 1,000,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001415889-18-001381 · form4-09132018_040911.xml · derivative · entry 1 Erickson James R. · CIK 0001714493 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2023-09-04 F1 · security: 625,000 stock options are fully vested with the remainder vesting monthly in equal increments over a 27 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date. F2 · price: Not applicable. Read SEC document |
| September 04, 2018 Filed Sep 13, 2018 20:05 UTC |
Wendt Kelley ACHIEF FIN OFFICER AND TREAS
|
GrantStock Options (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001415889-18-001380 · form4-09132018_040906.xml · derivative · entry 1 Wendt Kelley A · CIK 0001600504 · CHIEF FIN OFFICER AND TREAS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2023-09-04 F1 · security: 178,125 stock options are fully vested with the remainder vesting monthly in equal increments over a 15 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date. F2 · price: Not applicable. Read SEC document |
| September 04, 2018 Filed Sep 14, 2018 21:25 UTC Amendment |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT · 10% owner
|
GrantStock Options (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001415889-18-001393 · form4a-09142018_020937.xml · derivative · entry 1 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2023-09-04 F1 · security: 178,125 stock options are fully vested with the remainder vesting monthly in equal increments over a 15 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date. F2 · price: Not applicable. Read SEC document |
| September 04, 2018 Filed Sep 14, 2018 20:05 UTC |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT · 10% owner
|
GrantStock Options (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001415889-18-001390 · form4-09142018_040901.xml · derivative · entry 1 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2023-09-04 F1 · security: 178,125 stock options are fully vested with the remainder vesting monthly in equal increments over a 15 month period beginning on October 1, 2018, subject to execution of the Company's standard stock option agreement and continued service as an officer of the Company on each applicable vesting date. F2 · price: Not applicable. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 20:05 UTC |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT
|
GrantSeries D Preferred Stock (the "Series D") · Derivative | 16 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-001096 · form4-07092018_040701.xml · derivative · entry 6 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27 Underlying: Common Stock · 3,200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F3 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $200,000. F2 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 18:14 UTC |
Young Philip JPRES AND CHIEF EXEC OFFICER
|
GrantSeries D Preferred Stock (the "Series D") · Derivative | 11 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-000480 · form4-03302018_030350.xml · derivative · entry 1 Young Philip J · CIK 0001290682 · PRES AND CHIEF EXEC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 2,200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F3 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $137,500. F2 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 22:16 UTC |
Wendt Kelley ACHIEF FIN OFFICER AND TREAS
|
GrantSeries D Preferred Stock (the "Series D") · Derivative | 12 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-000483 · form4-03302018_030342.xml · derivative · entry 1 Wendt Kelley A · CIK 0001600504 · CHIEF FIN OFFICER AND TREAS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12 Underlying: Common Stock · 2,400,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F3 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $150,000. F2 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 22:16 UTC |
Ryan Timothy JohnDirector · EXECUTIVE VICE PRESIDENT
|
GrantSeries D Preferred Stock (the "Series D") · Derivative | 11 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-000482 · form4-03302018_030355.xml · derivative · entry 1 Ryan Timothy John · CIK 0001714656 · Director · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: Common Stock · 2,200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F3 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $137,500. F2 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 22:15 UTC |
Erickson James R.CHIEF BUSINESS OFFICER
|
GrantSeries D Preferred Stock (the "Series D") · Derivative | 6 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-18-000481 · form4-03302018_030301.xml · derivative · entry 1 Erickson James R. · CIK 0001714493 · CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Common Stock · 1,200,000 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series D automatically converts into 200,000 shares of the Company's common stock upon the consummation of the first offering of the Company's Common Stock, subsequent to the acquisition of the Series D, for which the gross proceeds of the offering exceed $5,000,000. F3 · price: The securities were issued in connection with the repayment of debt, owed by the Company to the Reporting Person, in the amount of $75,000. F2 · derivative.expiration_date: The Series D has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.